Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2012
Apr. 02, 2011
Operating activities    
Net income $ 1,337,269 $ 2,500,335
Adjustments to reconcile net income to net cash (used in) provided by continuing operating activities:    
Depreciation expense 706,341 767,829
Amortization of deferred charges 6,273 5,340
Deferred income taxes 67,068 62,072
Reduction of reserve for losses on accounts receivable (96,000) (54,000)
Provision for (reduction of) losses on inventory 286,250 (53,000)
Gain on sale of property, plant and equipment (41,724) (2,950)
Cash value of life insurance (161,436) (18,001)
Environmental reserves 11,055 8,016
Employee stock option and stock grant compensation 78,251 74,928
Changes in operating assets and liabilities:    
Accounts receivable (5,943,088) (9,403,803)
Inventories (1,050,844) (10,566,879)
Other assets and liabilities 57,890 78,574
Accounts payable 5,010,535 8,976,031
Accrued expenses 797,767 2,391,466
Income taxes payable 619,162 1,349,913
Net cash provided by (used in) operating activities 1,684,769 (3,884,129)
Investing activities    
Purchases of property, plant and equipment (525,004) (457,910)
Proceeds from sale of property, plant and equipment 77,500 2,950
Proceeds from life insurance 734,206 0
Net cash provided by (used in) investing activities 286,702 (454,960)
Financing activities    
Net (payments on) borrowings from long-term debt (1,967,026) 5,118,847
Proceeds from exercised stock options 0 550
Net cash (used in) provided by financing activities (1,967,026) 5,119,397
Increase in cash and cash equivalents 4,445 780,308
Cash and cash equivalents at beginning of period 110,138 108,902
Cash and cash equivalents at end of period $ 114,583 $ 889,210